Search:
www.en.lmu.de
|
Medical Faculty
|
Site Map
|
LMU-Portal
Announcements
About the SFB 684
Projects
A2 Thomas Cremer
A3 Karl-Peter Hopfner
A4 Heinrich Leonhardt
A6 Stefan Bohlander
A10 Dirk Eick
A11 Justus Duyster
A12 Karsten Spiekermann
A13 Ursula Strobl
A14 Timm Schroeder
A15 Jürgen Ruland
A17 Gunnar Schotta
A18 Marc Schmidt-Supprian
A19 Sandra Hake
A20 Arnd Kieser
A21 Stefan Müller
A22 Irmela Jeremias
Previous Projects
Contact
Startseite
> Projects
Projects
In the second funding period, the SFB 684 is comprised of 16 research projects.
A2 Thomas Cremer
Nuclear architecture in normal and malignant hematopoietic cell types studied by quantitative, correlative microscopy
[more]
A3 Karl-Peter Hopfner
Repair and signalling of DNA double-strand breaks in normal and malignant hematopoiesis is the main agenda.
[more]
A4 Heinrich Leonhardt
The role and regulation of DNA methylation in normal and malignant hematopoiesis
[more]
A6 Stefan Bohlander
A transgenic mouse model for CALM/AF10 leukemias
[more]
A10 Dirk Eick
Nucleolar targets of chemotherapy involved in cell cycle and growth control
[more]
A11 Justus Duyster
Validation of crucial signaling pathways in oncogene driven leukemias by an siRNA based in vivo approach
[more]
A12 Karsten Spiekermann
Mechanisms of leukemic transformation by the receptor tyrosine kinase FLT3 in vitro and in vivo
[more]
A13 Ursula Strobl
The role of Notch-signaling in B cell development, activation and lymphomagenesis
[more]
A14 Timm Schroeder
Molecular control of hematopoietic stem cell self renewal and differentiation
[more]
A15 Jürgen Ruland
MALT1 signaling in Lymphomagenesis
[more]
A17 Gunnar Schotta
Epigenetic regulation of hematopoiesis
[more]
A18 Marc Schmidt-Supprian
The ubiquitin-editing enzyme A20 in B cell physiology and malignancy
[more]
A19 Sandra Hake
Functional analysis of histone variants during normal and malignant hematopoiesis
[more]
A20 Arnd Kieser
The role of the germinal center kinase family member TNIK in hematopoiesis and signaling
[more]
A21 Stefan Müller
Functional Characterization of AML-associated Mutants of Nucleophosmin
[more]
A22 Irmela Jeremias
The effect of TRAIL on primary leukemia cells and leukemic stem cells
[more]
Imprint
-
Privacy Disclaimer
-
Contact
